Hantavirus—How It’s Different From COVID-19 And The U.S. Response

The recent hantavirus outbreak originating from a cruise ship in the Atlantic Ocean has caused alarm, resulting in three confirmed deaths and eight identified cases (five confirmed and three suspected). This strain of the hantavirus, known as the Andes strain, is rare and has the ability to spread from person to person, unlike most hantavirus cases that are transmitted through direct contact with infected rodents.

The World Health Organization is actively coordinating a global response to contain the virus and minimize the risk of further spread. The current risk to the global population is deemed low by the World Health Organization.

More than 100 passengers aboard the affected cruise ship are set to disembark in the Canary Islands for medical assessment this weekend. They will undergo testing and monitoring for symptoms, with potential isolation and quarantine measures for those displaying symptoms. U.S. passengers will be evacuated on a U.S. government flight to a quarantine center in Nebraska for further testing and isolation.

The hantavirus differs significantly from COVID-19 in terms of transmission and potential for a pandemic. Unlike COVID-19, which spread rapidly due to its high transmissibility through aerosol particles, the hantavirus spreads through prolonged, sustained contact and is less efficient in transmission. Additionally, the Andes variant of the hantavirus has been around since 1995, allowing for some level of immunity among the global population.

The United States has plans in place to transport remaining U.S. passengers to a quarantine center in Nebraska. Despite efforts from the CDC and federal government, there has been a lack of public education and awareness about the hantavirus outbreak. Recent layoffs within the Department of Health and Human Services have reduced the capacity for ship inspections, raising concerns about the country’s preparedness for handling public health outbreaks on cruise ships.

International coordination and investments in science, technology, and innovation are crucial for public health response. Transparent communication and trust are essential for individuals to make informed decisions about their health and well-being, as demonstrated by the lessons learned from the COVID-19 pandemic.